Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_assertion type Assertion NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_head.
- NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_assertion description "[The CYP1A1*2C (p = 0.011, OR: 6.62, and 95% CI: 1.56-28.10), GSTT1 null (p < or = 0.001, OR: 11.94, 95% CI: 7.88-18.12), and GSTP1 TT genotypes (p = 0.017, OR: 3.42, 95% CI 1.26-9.38) demonstrated significant association of DLBCL risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_provenance.
- NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_assertion evidence source_evidence_literature NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_provenance.
- NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_assertion SIO_000772 18203021 NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_provenance.
- NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_assertion wasDerivedFrom befree-2016 NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_provenance.
- NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_assertion wasGeneratedBy ECO_0000203 NP650611.RAaA6DnNQpm54AT_6tUeVNPvPUGVOmefZPnHBEXj62stc130_provenance.